Works matching IS 13866346 AND DT 2022 AND VI 52 AND IP 4

Results: 10

Questionnaire‐based approach to sleep‐wake disturbance in patients with chronic liver disease.
Published in:
Hepatology Research, 2022, v. 52, n. 4, p. 327, doi. 10.1111/hepr.13760
Publication type:
Article
Phase 2 study of avatrombopag in Japanese patients with chronic liver disease and thrombocytopenia.
Published in:
Hepatology Research, 2022, v. 52, n. 4, p. 371, doi. 10.1111/hepr.13755
By:
- Eguchi, Yuichiro;
- Takahashi, Hirokazu;
- Mappa, Silvia;
- Santagostino, Elena
Publication type:
Article
The ratio of serum des‐gamma‐carboxy prothrombin to tumor volume as a new biomarker for early recurrence of resected hepatocellular carcinoma.
Published in:
Hepatology Research, 2022, v. 52, n. 4, p. 381, doi. 10.1111/hepr.13750
By:
- Shimagaki, Tomonari;
- Yoshizumi, Tomoharu;
- Itoh, Shinji;
- Iseda, Norifumi;
- Tomiyama, Takahiro;
- Morinaga, Akinari;
- Wang, Huanlin;
- Kurihara, Takeshi;
- Nagao, Yoshihiro;
- Toshima, Takeo;
- Harada, Noboru;
- Kinjo, Nao;
- Maeda, Takashi;
- Mori, Masaki
Publication type:
Article
Issue Information.
Published in:
Hepatology Research, 2022, v. 52, n. 4, p. 325, doi. 10.1111/hepr.13655
Publication type:
Article
Biomarkers for predicting nucleos(t)ide analogs discontinuation and hepatitis B virus recurrence after drug withdrawal in chronic hepatitis B patients.
Published in:
Hepatology Research, 2022, v. 52, n. 4, p. 337, doi. 10.1111/hepr.13749
By:
- Luo, Mengqi;
- Zhou, Bin;
- Hou, Jinlin;
- Jiang, Deke
Publication type:
Article
Referral system has a diminished difference in the risk for hepatic encephalopathy development among each etiology in patients with acute liver injury.
Published in:
Hepatology Research, 2022, v. 52, n. 4, p. 401, doi. 10.1111/hepr.13744
By:
- Kakisaka, Keisuke;
- Suzuki, Yuji;
- Takahashi, Fumiaki;
- Takikawa, Yasuhiro
Publication type:
Article
Proposal for new sleep disorder criteria in patients with chronic liver disease: Influence of liver‐related complications.
Published in:
Hepatology Research, 2022, v. 52, n. 4, p. 364, doi. 10.1111/hepr.13731
By:
- Miyaaki, Hisamitsu;
- Hiraoka, Atsuhi;
- Haraguchi, Masafumi;
- Uojima, Haruki;
- Kawaratani, Hideto;
- Hiramatsu, Akira;
- Hanai, Tatsunori;
- Hiasa, Yoichi;
- Yoshiji, Hitoshi;
- Okita, Kiwamu;
- Nakao, Kazuhiko;
- Koike, Kazuhiko
Publication type:
Article
Response Evaluation Criteria in Cancer of the liver version 6 (Response Evaluation Criteria in Cancer of the Liver 2021 revised version).
Published in:
Hepatology Research, 2022, v. 52, n. 4, p. 329, doi. 10.1111/hepr.13746
By:
- Kudo, Masatoshi;
- Ikeda, Masafumi;
- Ueshima, Kazuomi;
- Sakamoto, Michiie;
- Shiina, Shuichiro;
- Tateishi, Ryosuke;
- Nouso, Kazuhiro;
- Hasegawa, Kiyoshi;
- Furuse, Junji;
- Miyayama, Shiro;
- Murakami, Takamichi;
- Yamashita, Tatsuya;
- Kokudo, Norihiro
Publication type:
Article
2‐Step PLT16‐AST44 method: Simplified liver fibrosis detection system in patients with non‐alcoholic fatty liver disease.
Published in:
Hepatology Research, 2022, v. 52, n. 4, p. 352, doi. 10.1111/hepr.13745
By:
- Fujimori, Naoyuki;
- Kimura, Takefumi;
- Tanaka, Naoki;
- Yamazaki, Tomoo;
- Okumura, Taiki;
- Kobayashi, Hiroyuki;
- Wakabayashi, Shun‐ichi;
- Yamashita, Yuki;
- Sugiura, Ayumi;
- Pham, Jonathan;
- Pydi, Sai P.;
- Sano, Kenji;
- Joshita, Satoru;
- Umemura, Takeji
Publication type:
Article
Ratio of von Willebrand factor antigen to ADAMTS13 activity is a useful biomarker for acute‐on‐chronic liver failure development and prognosis in patients with liver cirrhosis.
Published in:
Hepatology Research, 2022, v. 52, n. 4, p. 390, doi. 10.1111/hepr.13743
By:
- Enomoto, Masahide;
- Takaya, Hiroaki;
- Namisaki, Tadashi;
- Fujinaga, Yukihisa;
- Nishimura, Norihisa;
- Sawada, Yasuhiko;
- Kaji, Kosuke;
- Kawaratani, Hideto;
- Moriya, Kei;
- Akahane, Takemi;
- Inoue, Takashi;
- Matsumoto, Masanori;
- Yoshiji, Hitoshi
Publication type:
Article